Status:
COMPLETED
The VEPRO Trial: A Cross-Over Randomised Controlled Trial Comparing 2 Corrective Lenses for Patients With Presbyopia
Lead Sponsor:
Santéclair
Conditions:
Presbyopia
Eligibility:
All Genders
43-60 years
Phase:
NA
Brief Summary
The VEPRO trial is a cross-over randomised controlled trial comparing 2 corrective lenses for patients with presbyopia. The aim of the study is to compare the effectiveness of two corrective lenses: a...
Eligibility Criteria
Inclusion
- age 43 to 60 years old
- outpatients wearing corrective lenses for presbyopia, referred to an optician within the last 6 months for a change in their optical correction
- associated hyperopia or astigmatism, the required correction had to be ≤ 3 dioptres in that case
- understanding, speaking French and able to answer a questionnaire
Exclusion
- first prescription of corrective lenses for presbyopia
- associated strabism
- associated amblyopia
- orthoptics therapy
- associated anisometropia \> 1.5 dioptres
- patients treated for diabetes
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
127 Patients enrolled
Trial Details
Trial ID
NCT00635115
Start Date
February 1 2006
End Date
January 1 2007
Last Update
March 13 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
INSERM, U738, Paris, France ; Université Paris 7 Denis Diderot, UFR de Médecine, Paris, France ; AP-HP, Hôpital Bichat, Département d'Epidémiologie, Biostatistique et Recherche Clinique
Paris, France, 75018